Dr. Elham Kazemirad | Treatment for Infectious Diseases | Excellence in Research

Published on by Infectious

Dr. Elham Kazemirad | Treatment for Infectious Diseases | Excellence in Research

Dr. Elham Kazemirad | Treatment for Infectious Diseases - Department of Medical parasitology & Mycology, Tehran University of Medical Sciences , Iran

Dr. Elham Kazemirad is a renowned Associate Professor at the Department of Medical Parasitology and Mycology, Tehran University of Medical Sciences. Her research bridges clinical and molecular diagnostics, with a central focus on Treatment for Infectious Diseases. Over the years, her contributions have emphasized Treatment for Infectious Diseases across leishmaniasis, Acanthamoeba keratitis, and protozoan infections. Her work consistently explores innovative diagnostic and therapeutic strategies, reinforcing global capabilities in Treatment for Infectious Diseases. With a dynamic presence in academia, she has dedicated her career to advancing Treatment for Infectious Diseases through cutting-edge molecular biology, gene expression studies, and nanoparticle drug delivery. Dr. Kazemirad’s leadership and research continue shaping new pathways for Treatment for Infectious Diseases in both clinical and research settings.

AUTHOR PROFILE

ORCID | GOOGLE SCHOLAR

EDUCATION

Dr. Kazemirad holds a Ph.D., M.Sc., B.Sc., and Associate Degree in Medical Parasitology and Laboratory Sciences, all from top Iranian medical universities. Her Ph.D. thesis pioneered gene profiling in Leishmania tropica and explored mechanisms of drug resistance, directly contributing to Treatment for Infectious Diseases. Throughout her academic path, Treatment for Infectious Diseases remained a core theme, evident in her early thesis on PCR diagnostics and parasite detection. Her educational foundation was rigorously rooted in scientific innovation and clinical relevance, always aimed at improving Treatment for Infectious Diseases. This background has propelled her to become a thought leader whose educational milestones support groundbreaking discoveries in the Treatment for Infectious Diseases field.

PROFESSIONAL EXPERIENCE

Dr. Kazemirad has served as an Assistant and Associate Professor, and lab supervisor, contributing significantly to Treatment for Infectious Diseases since 2014. Her clinical laboratory leadership includes molecular diagnosis of parasitic diseases, microbial keratitis, and more, always reinforcing effective Treatment for Infectious Diseases. She combines teaching, clinical, and administrative roles to shape future parasitologists and advance diagnostics. At both Tehran University of Medical Sciences and Pasteur Institute of Iran, her dedication has been a cornerstone in Treatment for Infectious Diseases. She mentors students and leads research initiatives that redefine how Treatment for Infectious Diseases is applied and understood across academic, diagnostic, and healthcare platforms.

RESEARCH INTEREST

Dr. Kazemirad’s primary research interests center on drug resistance mechanisms, molecular diagnostics, and nanomedicine—all critical for effective Treatment for Infectious Diseases. Her passion for Treatment for Infectious Diseases drives projects involving gene expression in pathogens and the development of novel therapeutics. With expertise in biotechnology, immunology, and phylogenetics, she investigates the molecular basis of resistance and innovative drug delivery systems. Treatment for Infectious Diseases is not only her research focus but her mission. By integrating bioinformatics, molecular assays, and nanoparticle therapeutics, her research contributes vital knowledge and practical tools to improve Treatment for Infectious Diseases, especially among vulnerable and immunocompromised populations.

AWARD AND HONOR

Dr. Kazemirad has been consistently recognized for her academic excellence and innovation in Treatment for Infectious Diseases. She was ranked first in multiple academic programs and received distinctions for her graduate work in drug-resistant Leishmania. Her work in Treatment for Infectious Diseases has been honored through leadership roles in scientific congresses and editorial positions in top journals. These honors reflect her relentless commitment to advancing Treatment for Infectious Diseases through translational research and public health applications. The prestigious recognition from both Iranian and international institutions underscores her profound impact on Treatment for Infectious Diseases and her standing as a key contributor in parasitological and biomedical sciences.

RESEARCH SKILL

Dr. Kazemirad is proficient in molecular diagnostics, gene expression analysis, animal modeling, and nanoparticle-based therapeutics, all pivotal for enhancing Treatment for Infectious Diseases. Her skill set includes advanced techniques such as RT-PCR, Western blotting, cloning, proteomics, ELISA, gene silencing, and next-generation sequencing. Each technique is applied to understand, monitor, and improve Treatment for Infectious Diseases. Her expertise extends to developing diagnostic platforms for Acanthamoeba and Leishmania, along with testing novel compounds and nanoparticles. Treatment for Infectious Diseases is the core of her methodological approach, combining lab innovation with clinical relevance to transform how these diseases are managed and treated across diverse populations.

PUBLICATIONS

Dr. Kazemirad has authored over 50 peer-reviewed papers, all thematically aligned with Treatment for Infectious Diseases. Her publications focus on antimony resistance, nanoparticle therapies, gene expression in pathogens, and diagnostics for parasitic diseases. Each study enhances global strategies for Treatment for Infectious Diseases, often addressing neglected tropical diseases. Her work appears in top journals such as PLOS ONE, BMC Infectious Diseases, Acta Tropica, and the Iranian Journal of Parasitology. Her contributions serve as foundational references for researchers developing new modalities in Treatment for Infectious Diseases, bridging fundamental biology and translational medicine. The consistency and depth of her publications emphasize her leadership in Treatment for Infectious Diseases.

  • Title: Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice
    Authors: Saberi, M.; Latifi, A.; Golkar, M.; Fard-Esfahani, P.; Mohtasebi, S.; Teimouri, A.; Afshar, M.J.A.; Kazemirad, E.; Mohebali, M.
    Journal: PLoS Neglected Tropical Diseases

  • Title: High Prevalence of Enterocytozoon bieneusi Genotype BEB6 in Wild Boars in Lorestan Province, Iran: Potential Source of Zoonotic Transmission
    Authors: Javanmard, E.; Mohammad Rahimi, H.; Taghipour, A.; Nemati, S.; Mohebali, M.; Rezaeian, M.; Badrifar, A.; Kazemirad, E.; Mirjalali, H.
    Journal: Iranian Journal of Parasitology

  • Title: Molecular Identification of Nematodes (Superfamily: Strongylida) Traced in Herbivores Excrement in the Wildlife from Western Iran
    Authors: Vafaei, M.R.; Safaie, M.; Kazemirad, E.; Mirjalali, H.; Askari, Z.; Mohebali, M.; Mowlavi, G.
    Journal: SSRN

  • Title: Prevalence of free-living amoebae in five rivers associated with high human activity in Tehran province, Iran
    Authors: Javanmard, E.; Kazemirad, E.; Rahimi, H.M.; Mohebali, M.; Rezaeian, M.; Alimohammadi, M.; Mirjalali, H.
    Journal: Journal of Water and Health

  • Title: Transcriptional alterations of virulence factors in Leishmania major clinical isolates harboring Leishmania RNA virus 2 (LRV2)
    Authors: Sabeti, S.; Koosha, M.; Kazemirad, E.; Mirabedini, Z.; Mohebali, M.; Saberi, R.; Fakhar, M.; Hajjaran, H.
    Journal: BMC Infectious Diseases

CONCLUSION

Dr. Elham Kazemirad’s career epitomizes dedication to the Treatment for Infectious Diseases. Through her education, research, and professional engagements, she has elevated global understanding of parasitic diseases and their therapies. Her work integrates basic science and clinical innovation to offer novel solutions for Treatment for Infectious Diseases. From academic contributions to pioneering diagnostics and therapies, her impact is profound and ongoing. She remains a key influencer in shaping policies, mentoring future scientists, and leading research that targets resistant pathogens. As Treatment for Infectious Diseases continues to challenge global health, her expertise remains vital in guiding next-generation therapeutic advancements and public health solutions

Souhir Belloumi – Antibiotics – Best Researcher Award

Published on by Infectious

Souhir Belloumi - Antibiotics - Best Researcher Award

Faculty of Sciences of Tunis and Center of Biotechnology of Borj Cedria - Tunisia

AUTHOR PROFILE

SCOPUS

🌟 INTRODUCTION TO ANTIBIOTICS RESEARCH EXCELLENCE

Souhir Belloumi is a dedicated junior researcher in Biological Sciences with a robust foundation in medical biotechnology, food preservation, and molecular biology. Her academic and professional trajectory reveals an intense focus on bioactive compounds, environmental applications, and especially the antimicrobial properties of essential oils as natural Antibiotics. Souhir has persistently explored how plant-derived substances function as sustainable and potent alternatives to conventional Antibiotics, particularly within the poultry and food industries. Her passion for Antibiotics stems from her early research days, where she discovered a unique niche between traditional botanical medicine and modern biochemical sciences. This interdisciplinary approach is central to her work, allowing her to contribute meaningful insights into the efficacy and shelf-life improvement of natural preservatives. With numerous scientific publications addressing the antibacterial, antifungal, and antioxidant properties of plant extracts, Souhir continually emphasizes the public health impact of Antibiotics derived from nature. Her contributions extend beyond lab-based experiments—she has worked with international institutions and industrial partners, reinforcing the applicability of her research. Through strategic innovation in essential oil chemistry and Antibiotics formulation, Souhir Belloumi demonstrates leadership in developing biopreservatives that serve both environmental and human health agendas, pushing the boundaries of what Antibiotics research can achieve in the 21st century.

📚 EARLY ACADEMIC PURSUITS IN ANTIBIOTICS SCIENCE

Souhir Belloumi’s academic journey into the field of Antibiotics began with a Bachelor's in Medical Biotechnology focused on Molecular Engineering from the University of Tunis El-Manar. Her early exposure to molecular microbiology and diagnostic kit development at the Pasteur Institute in Tunisia gave her foundational knowledge in DNA/RNA extraction, PCR techniques, and vaccine research, which are essential pillars in Antibiotics discovery and delivery. During her dual Master’s programs in Environment Biomonitoring and Biological Sciences, she developed a keen interest in the intersection of environmental factors and microbial resistance, particularly as it applies to naturally occurring Antibiotics in plant systems. Her PhD research at the University of Tunis El-Manar further honed her focus on the biological effects of essential oils, where she pioneered analytical techniques using LC-MS/MS to characterize plant compounds for Antibiotics potential. Her academic success was marked by hands-on research that continually returned to the central theme of natural Antibiotics, culminating in advanced knowledge of their chemical composition, antibacterial mechanisms, and preservation roles. These formative experiences shaped Souhir’s vision of advancing global health through sustainable Antibiotics, fusing molecular biology with nature’s own antimicrobial arsenal. Her education laid the groundwork for innovative, translational Antibiotics research.

🧪 PROFESSIONAL ENDEAVORS IN ANTIBIOTICS INNOVATION

Souhir Belloumi’s professional trajectory demonstrates her deep commitment to advancing Antibiotics research, particularly through applied biotechnology and food science. As a research scientist at the Laboratory of Bioactive Substances at the Center of Biotechnology of Borj-Cedria, she led studies focused on isolating bioactive compounds and testing their Antibiotics capabilities, especially within the poultry industry. Her collaboration with Poulina Holdings enabled the transition of lab-based discoveries into scalable industrial applications, offering natural Antibiotics alternatives that align with consumer safety and environmental responsibility. During her tenure as a research intern at the University of Pisa’s Department of Pharmacy, she worked on cutting-edge compound identification using LC-MS/MS, contributing to the broader pharmacognosy field and enhancing understanding of plant-derived Antibiotics. Her international experience bolstered her analytical skills and exposed her to interdisciplinary perspectives on Antibiotics efficacy. In every professional role, whether in Tunisia or abroad, Souhir maintained a steadfast focus on developing efficient, eco-friendly Antibiotics solutions that tackle microbial resistance without contributing to chemical pollution. Her contributions also span virology, environmental microbiology, and food analysis—each reinforcing the central role of Antibiotics in human and animal health. Her work not only bridges disciplines but redefines the role of natural Antibiotics in global antimicrobial strategies.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ANTIBIOTICS

Souhir Belloumi’s research contributions focus predominantly on the development and evaluation of bioactive compounds as viable Antibiotics alternatives. She has co-authored multiple peer-reviewed articles analyzing the antimicrobial and antioxidant potentials of essential oils such as Schinus molle and Tetraclinis articulata, exploring their synergy and effectiveness against various foodborne pathogens. These studies demonstrated how plant-derived Antibiotics can extend shelf life, maintain food safety, and combat resistant strains. Her work has gone beyond identification, venturing into the mechanistic pathways of how these Antibiotics act on microbial cells. Souhir’s focus on fractionation, compound purification, and chemical profiling via GC-MS and LC-MS/MS tools has made her a leading figure in natural Antibiotics analysis. Furthermore, her interdisciplinary methodology integrates food chemistry, microbiology, and immunology, emphasizing how natural preservatives can act as potent Antibiotics. By blending sensory evaluation with microbial inhibition assays, she provides a comprehensive approach to natural preservative development. Her research significantly contributes to the growing discourse on antimicrobial resistance, offering a nature-based solution. Through her dedication to Antibiotics innovation, she has helped establish evidence-based practices for utilizing essential oils in both medical and food-related applications, ensuring a sustainable and health-conscious future grounded in natural Antibiotics research.

🏅 ACCOLADES AND RECOGNITION IN ANTIBIOTICS SCIENCE

Souhir Belloumi’s work in Antibiotics research has garnered increasing recognition, particularly in international scientific circles focused on food safety and natural therapeutics. Her publication in Food Chemistry on essential oils as chicken meat preservatives is widely cited, highlighting her critical role in the advancement of natural Antibiotics applications. Her collaborative efforts with national and international laboratories have been praised for their methodological rigor and relevance in the context of antimicrobial resistance. Souhir has completed multiple prestigious certifications, including Statistical Analysis and QSE System Management, further solidifying her technical and regulatory expertise within the Antibiotics field. Her participation in the GIZ Master-Class in Germany demonstrates her leadership potential in managing interdisciplinary research on water and health sciences, closely related to microbial control via Antibiotics. These experiences have strengthened her capacity to act as a global voice in antimicrobial innovation. She is often acknowledged for integrating statistical modeling with chemical and microbiological evaluation to validate the efficacy of new Antibiotics solutions. In every professional development endeavor, the common thread is her emphasis on effective, safe, and environmentally sustainable Antibiotics technologies. Her awards and recognitions underscore her role as an emerging leader in natural Antibiotics discovery and deployment for both public health and industrial needs.

🌍 IMPACT AND INFLUENCE THROUGH ANTIBIOTICS RESEARCH

Souhir Belloumi’s influence extends across the domains of microbiology, biotechnology, and environmental health, all rooted in the powerful application of Antibiotics derived from natural sources. Her interdisciplinary research has impacted food preservation practices by introducing natural Antibiotics as effective alternatives to synthetic chemical preservatives. This has vast implications for reducing antimicrobial resistance globally. By collaborating with academic institutions, industrial sectors, and research labs in Tunisia and Europe, Souhir has fostered knowledge exchange that drives innovation in natural Antibiotics. Her mentoring of peers and sharing of experimental design insights has inspired a new generation of scientists to pursue research focused on sustainable Antibiotics. The broader health community benefits from her findings, especially in regions vulnerable to foodborne illness and limited pharmaceutical access. Her advocacy for integrating essential oils into public health frameworks contributes to national discussions on safe Antibiotics use in agriculture and food production. In scholarly forums and industry settings, Souhir promotes the role of bio-based Antibiotics in achieving both food security and antimicrobial stewardship. Her contributions continue to shape policy, inspire innovation, and enhance global understanding of natural Antibiotics as not just alternatives—but as necessities—in the fight against microbial threats.

🧬 LEGACY AND FUTURE CONTRIBUTIONS IN ANTIBIOTICS SCIENCE

Looking ahead, Souhir Belloumi envisions a future where Antibiotics derived from natural sources are central to global antimicrobial policy, sustainable agriculture, and health innovation. Her legacy is already taking form through her influential publications, global collaborations, and a clear focus on integrating essential oils and botanical extracts into mainstream Antibiotics strategies. With antimicrobial resistance posing a growing global threat, she plans to extend her research to cover synergistic formulations that enhance the potency of plant-based Antibiotics while minimizing cytotoxicity and side effects. Her next frontier includes exploring nanotechnology for enhanced delivery of Antibiotics compounds, potentially revolutionizing how infections are managed in both humans and animals. She is committed to educating future scientists, advocating for environmentally conscious Antibiotics development, and influencing health policies that embrace nature-based solutions. Through continuous innovation, publication, and public engagement, Souhir aims to establish international research platforms that prioritize natural Antibiotics over synthetic alternatives. Her enduring goal is to ensure that global communities, especially in the Global South, have access to affordable, effective, and sustainable Antibiotics. This vision cements her status as a pioneer in shaping a future where Antibiotics are no longer pollutants but protectors—rooted in nature, validated by science, and embraced by society.

NOTABLE PUBLICATION

  • Title: Combined essential oils as natural chicken meat preservatives: chemical composition, biological activities, synergy and shelf-life extension potential
    Authors: (Not fully listed in your message – please provide full author list or upload the article if you have it)
    Journal: Food Chemistry
    Year: 2025

ADELAIDA LAMAS FERREIRO – Antibiotic – Best Researcher Award

Published on by Infectious

ADELAIDA LAMAS FERREIRO - Antibiotic - Best Researcher Award

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL. UNIVERSIDAD DE ALCALÁ. MADRID - Spain

AUTHOR PROFILE

GOOGLE SCHOLAR

INTRODUCTION TO A LIFETIME OF CARE 🌍

Dr. Adelaida Lamas stands as a remarkable figure in pediatric pulmonology, with an illustrious career centered on cystic fibrosis and the vital role of antibiotic therapies. Her clinical dedication has spanned more than two decades, particularly in respiratory medicine, where her expertise has reshaped the management of chronic infections in pediatric patients. She has led national efforts to refine antibiotic administration strategies in cystic fibrosis, directly influencing treatment protocols and patient outcomes. As the principal investigator at the Ramón y Cajal Institute for Health Research (IRYCIS), she spearheaded pioneering research in pulmonary microbiology, emphasizing the interplay between antibiotics and microbial resistance. Her advocacy for inhaled antibiotic therapies was instrumental in expanding access to life-prolonging treatments. From neonatology to intensive care, Dr. Lamas’s practice was always anchored in evidence-based medicine and ethical care. Her guidance as an expert with the Spanish Agency for Medicines and Health Products (AEMPS) further established her as a key voice in antibiotic evaluation and therapeutic positioning. Dr. Lamas’s work not only provided clinical clarity but also raised the standard of care across Europe. Through antibiotic-driven protocols, she has improved survival and quality of life for countless children. Her legacy begins here, with antibiotics at its heart.

EARLY ACADEMIC PURSUITS 📚

Adelaida Lamas’s journey into pediatric pulmonology and antibiotic therapeutics began with rigorous medical education at the Universidad de Valladolid, followed by her specialization at the Ramón y Cajal University Hospital. Her early academic focus was deeply rooted in pediatric respiratory pathophysiology, especially how antibiotics influence outcomes in cystic fibrosis and critical care. During her doctoral studies at the Universidad Autónoma de Madrid, her award-winning thesis examined sedation monitoring in critically ill children—a project intersecting with the timing and dosing of antibiotics in intensive care. Her early exposure to pediatric infectious disease units shaped her understanding of antibiotic resistance, prompting her to explore novel modes of delivery like aerosolized antibiotics for neonatal care. She also participated in cross-institutional training in Spain and the United States, further deepening her comprehension of global antibiotic stewardship. These foundational years fostered her lifelong commitment to evidence-based antibiotic applications. Recognizing the intricacies of microbiome-antibiotic interactions, she published early papers that addressed microbial colonization in children and the antibiotic responses in respiratory infections. Her training laid a powerful groundwork, allowing her to rise not just as a clinician, but as an antibiotic-conscious academic. This early pursuit set the tone for decades of innovation centered on children’s health and antibiotic optimization.

PROFESSIONAL ENDEAVORS 🏥

Dr. Adelaida Lamas’s professional career spans over 25 years, during which she served as a consultant pediatric pulmonologist at the Ramón y Cajal University Hospital. There, she became the national reference point for cystic fibrosis management and antibiotic strategy development. One of her hallmark contributions was leading the design and oversight of antibiotic protocols within Spain’s CF newborn screening programs. Her expertise expanded into bioethics and clinical decision-making, where she lectured extensively on the appropriate use of antibiotics in pediatric populations. As a member of multiple national and international ethics and clinical trial committees, she advocated for safe and timely antibiotic use in vulnerable children. She also evaluated pediatric antibiotics for the Spanish Agency for Medicines and Health Products (AEMPS), helping shape regulatory decisions. Through her work with the European clinical trials initiative (Conect4children), she contributed to global guidelines for pediatric antibiotic trials. Her involvement in therapeutic positioning reports for inhaled antibiotics like tobramycin and aztreonam further positioned her as a thought leader in this field. Her daily practice married compassion with precision, always anchored in responsible antibiotic use. Dr. Lamas not only advanced care but reshaped antibiotic discourse in pediatrics through decades of resolute clinical endeavor and scholarly service.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬

Throughout her prolific research career, Dr. Adelaida Lamas has published over 35 high-impact studies that focus on the intersection of pulmonary infections and antibiotic effectiveness in children with cystic fibrosis. Her groundbreaking work explored biofilm dynamics and how early antibiotic intervention alters pathogen colonization in respiratory tracts. She led key studies on the inhaled use of aztreonam, tobramycin, and other novel antibiotics that redefined how recurrent Pseudomonas aeruginosa infections are managed in chronic respiratory diseases. With collaborators from top European institutions, she investigated antibiotic heterogeneity and its role in resistance modulation. A strong advocate for combining antibiotics with probiotics, Dr. Lamas contributed to integrative therapeutic models that reduced microbial imbalance in CF patients. Her work in metaproteomics and gut microbiota establishment further emphasized the systemic effects of prolonged antibiotic use, positioning her as a forerunner in microbiome-aware therapy. Her leadership in randomized controlled trials ensured the ethical and scientific rigor of new antibiotic formulations. Her team’s publications are now widely cited in CF and pediatric pulmonology literature, influencing clinical guidelines across Europe. In short, her research has consistently pushed forward the boundaries of antibiotic science, ensuring that every child treated today benefits from decades of careful, research-driven innovation.

ACCOLADES AND RECOGNITION 🏅

Dr. Adelaida Lamas’s exceptional contributions to pediatric pulmonology and antibiotic therapies have garnered widespread recognition across clinical, academic, and governmental institutions. In 2006, her doctoral thesis received Spain’s “Dra. Juana Román First Prize,” the highest national honor in pediatric research. Her continued leadership earned her a permanent seat at the Spanish Agency for Medicines and Health Products (AEMPS), where she advised on pediatric antibiotic approvals. As principal investigator of several national and European antibiotic-related trials, she secured funding from global pharmaceutical leaders including Gilead and AstraZeneca. These trials revolutionized how antibiotic inhalation therapies are evaluated and prescribed for cystic fibrosis patients. Her recognition extended internationally when she was appointed as a key expert in pediatric pulmonology for Conect4children (c4c), shaping pan-European guidelines on antibiotic use in pediatric trials. Her teaching excellence earned her appointments at the Universidad de Alcalá and the International University of La Rioja, where she taught ethics in the use of antibiotics. Her voice is respected in editorial boards and therapeutic committees, particularly those focused on antibiotic innovation. In every honor received, the thread of her dedication to safe and effective antibiotic use in children remains central. Recognition of her work reflects the enduring impact of her antibiotic-focused legacy.

IMPACT AND INFLUENCE 🌐

The influence of Dr. Adelaida Lamas extends beyond the boundaries of her hospital and even her country. Her work in optimizing antibiotic protocols for pediatric pulmonology has inspired health policy reforms and research innovations globally. As one of the earliest adopters of inhaled antibiotic therapies, she helped bring these strategies from niche practices into standard protocols for cystic fibrosis patients. Her lectures on antibiotic resistance, ethical stewardship, and individualized therapy have been delivered across Europe and Latin America, where her voice commands respect and attention. Dr. Lamas’s influence is evident in international registries and multi-center trials, where her research and clinical models have been replicated. She has contributed significantly to the Spanish Federation of Cystic Fibrosis, promoting antibiotic literacy among patients and caregivers. Under her guidance, new pediatric pulmonologists have emerged, many of whom now lead CF units inspired by her antibiotic-focused methodologies. Her role in ethics committees ensured that antibiotic trials respect both safety and urgency—setting a benchmark for pediatric medicine. Dr. Lamas continues to shape antibiotic narratives through advisory boards, regulatory commissions, and academic forums. Her broad impact lies in proving that antibiotics, when used judiciously, are not just drugs—they are lifelines forged through science and compassion.

LEGACY AND FUTURE CONTRIBUTIONS 🌱

As Dr. Adelaida Lamas transitions from her active clinical roles, her legacy in pediatric pulmonology and antibiotic stewardship continues to flourish. She has trained countless professionals who now carry her antibiotic philosophy into new generations of care. Her published works serve as cornerstone references in antibiotic-based CF management and are embedded in Spain’s national respiratory care protocols. Beyond academia and hospitals, her advocacy has reached families and patients directly, helping demystify antibiotic use and resistance. Her future impact will unfold through her ongoing doctoral advisement roles, where she continues to guide research in hypertonic saline, probiotics, and next-generation antibiotics. She is also shaping ethical standards for emerging pediatric trials involving biologics and gene therapies, where the antibiotic baseline remains critical for infection control. With a strong foundation in both research and humanistic care, Dr. Lamas’s voice will remain central in regulatory debates and academic dialogues. Her legacy is proof that when science, ethics, and heart converge—especially around something as vital as antibiotics—the result is transformative. Looking ahead, she aims to contribute further by writing, mentoring, and consulting, all while ensuring that antibiotics remain a tool of precision, protection, and possibility for the children of tomorrow.

NOTABLE PUBLICATION

  • Title: Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
    Authors: P. Mondejar-Lopez, E. Quintana-Gallego, R.M. Giron-Moreno, et al.
    Journal: Respiratory Medicine, Vol. 170, Article 106062, 2020

  • Title: Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis
    Authors: M.C. Megías, O.G. Albarrán, P.G. Vasco, A.L. Ferreiro, L.M. Carro
    Journal: Endocrinología y Nutrición (English Edition), Vol. 62(2), Pages 91–99, 2015

  • Title: A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomics
    Authors: Ó. Pastor, P. Guzmán-Lafuente, J. Serna, M. Muñoz-Hernández, A.L. Neyra, et al.
    Journal: The Journal of Nutritional Biochemistry, Vol. 63, Pages 197–205, 2019

  • Title: Protocol for the diagnosis and follow up of patients with cystic fibrosis
    Author: S. Gartner
    Journal: Anales de Pediatría (Barcelona, Spain: 2003), Vol. 71(3), Pages 250–264, 2009

  • Title: Tolerance of two inhaled hypertonic saline solutions in patients with cystic fibrosis
    Authors: L.M. Carro, A.L. Ferreiro, M.R. de Valbuena Maiz, C.W. Struwing, G.G. Álvarez, et al.
    Journal: Medicina Clínica, Vol. 138(2), Pages 57–59, 2012

Moncef Chouaibi – Treatment for Infectious Diseases – Best Academic Researcher Award

Published on by Infectious

Moncef Chouaibi - Treatment for Infectious Diseases - Best Academic Researcher Award 

Higher School of Food Industries of Tunis - Tunisia

AUTHOR PROFILE

ORCID

🎓 EARLY ACADEMIC PURSUITS

Professor Moncef Chouaïbi's academic journey reflects a strong foundation in mathematical sciences and food engineering. He began with a Bachelor of Mathematics from 1996 to 2000, which laid the groundwork for his analytical approach in later scientific explorations. He pursued an engineering diploma, master’s, and ultimately a PhD in Food Industries between 2000 and 2013 from the University of Carthage and the University of Salerno. His doctoral studies focused on food engineering and preservation technologies, critical to public health, especially in regions facing foodborne infections. During these formative years, he developed a keen interest in the optimization of extraction processes, thermal food treatment, and encapsulation of bioactive compounds—techniques that today underpin innovations in antimicrobial food systems. His early academic path emphasized both theoretical mastery and applied research, equipping him with the scientific literacy and lab-based expertise to address complex problems in food safety and infectious disease management. His studies incorporated methodologies that enhance food functionality while limiting pathogen transmission—a core concern in infectious disease control. This period was not just a phase of learning but also a springboard for his later contributions to microbiologically safe and nutritionally enhanced food products.

🧪 PROFESSIONAL ENDEAVORS IN FOOD SCIENCE

Since the early stages of his career, Professor Chouaïbi has devoted himself to the advancement of food engineering with a strong focus on safety, stability, and nutrition. Starting as a Senior Research Fellow in Tunis and later in Salerno, Italy, he quickly transitioned into academic leadership as an Assistant Professor and eventually as a full Professor at the Higher School of Food Industries of Tunis. His teaching and mentoring have supported a new generation of scientists, but it is his research that sets him apart. He has actively explored the use of natural preservatives, bioactive components, and rheological food properties to improve food quality and safety. This work is especially relevant in developing countries where infectious diseases are often exacerbated by compromised food systems. By modeling heat and mass transfer, Professor Chouaïbi has helped design preservation techniques that reduce microbial load in food, directly contributing to infectious disease prevention. He has also collaborated with biotechnology and food chemistry experts to create functional foods that boost immune responses. His hands-on approach and strategic focus on real-world applications of food science make his professional journey a beacon for interdisciplinary innovation in nutrition and public health.

🧬 RESEARCH ON FUNCTIONAL FOODS & BIOACTIVE COMPOUNDS

Professor Moncef Chouaïbi has established himself as a pioneering researcher in the field of functional foods and bioactive compound extraction. His studies on antioxidant-rich oils, including those derived from pumpkin, celery, and Zizyphus lotus, demonstrate his commitment to exploring nature-derived solutions to public health challenges. Many of these compounds, such as polyphenols and flavonoids, have demonstrated antimicrobial and antiviral properties, making them potential adjuncts in infectious disease treatment. His innovative work on encapsulation technology—particularly nanoemulsions and double emulsions—has enabled targeted delivery of these compounds, enhancing their stability and efficacy. These advances have broad implications in the management of bacterial and viral foodborne illnesses, especially in vulnerable populations. His research is widely published in high-impact journals, evidencing both depth and breadth. Through projects like yogurt fortified with inulin or camel milk enhanced with probiotics, he combines scientific rigor with nutritional foresight. His exploration of shelf-life enhancement and preservation methods directly addresses contamination and disease spread in perishable goods. Such applications play a crucial role in food systems resilience against pathogens, including those that cause enteric infections. His work positions food not only as sustenance but as a strategic platform for disease intervention.

🧫 ADVANCES IN INFECTIOUS DISEASE TREATMENT VIA FOOD SCIENCE

Professor Chouaïbi's contributions have extended beyond traditional food science into the realm of infectious disease treatment and prevention. His application of bioactive-rich emulsions and coatings—such as thyme essential oil encapsulation and almond gum films—offers a sustainable, chemical-free alternative to conventional disinfectants. These formulations are especially effective against microbial spoilage and contamination, which are common vectors for infectious disease transmission through food. His collaborations have resulted in yogurt enriched with antimicrobial agents and functional cheeses with targeted probiotic properties, both of which support gastrointestinal health and immunological defense. His work on modeling urease activity reduction in soybean meals and optimizing drying processes has clinical relevance in reducing pathogen viability. Furthermore, his patents on emulsifiers and encapsulation systems are setting new standards in controlled delivery of anti-pathogenic agents. As diseases evolve and antibiotic resistance grows, the integration of food engineering in the fight against infections becomes increasingly vital. Through his food-based biotechnological innovations, Professor Chouaïbi is contributing practical tools that align nutrition with infection control, reinforcing the interdisciplinary bridge between food technology and public health.

📚 EDITORIAL AND SCHOLARLY IMPACT

Beyond research and teaching, Professor Chouaïbi holds influential editorial roles in several international journals including Discover Food, Journal of Food Measurement and Characterization, and Frontiers in Materials. These positions affirm his global recognition as an authority in food engineering. His role as guest editor and board member enables him to shape emerging discourses around sustainable food systems, food safety, and biofunctional ingredients. He has authored multiple books and book chapters that explore food preservation technologies, phytochemicals, and encapsulation techniques—many of which serve as reference texts in food and nutrition science. His scholarly contributions provide critical frameworks for understanding how food technology can mitigate microbial risks. Through peer review and journal leadership, he fosters innovation, ensures scientific rigor, and promotes cross-border collaborations. This academic leadership enhances not just his personal standing but also the integrity and visibility of food science research in developing infectious disease interventions. By mentoring young scientists and influencing research directions globally, Professor Chouaïbi multiplies his impact, ensuring the continuity and evolution of science-based solutions to pressing health threats.

🏆 HONORS, PATENTS & INTERNATIONAL COLLABORATIONS

Professor Moncef Chouaïbi’s excellence has been acknowledged through various honors, patents, and extensive international engagements. He is a patent holder for technologies including novel emulsifiers for drug delivery and food coating systems with bioactive properties, which support food safety and infectious disease mitigation. These innovations provide scalable solutions for controlling contamination in food supply chains. His scientific influence spans across borders with collaborative research in Italy, Japan, and across North Africa. Participation in international conferences—from the Euro-Global Conference on Food Science to Japan-Tunisia symposia—underscores his reputation as a global expert. His patented work on the use of natural polymers and biopolymers in preserving food integrity has found use in both academic and industrial settings. These achievements not only validate his research but also position his methodologies as models for innovation in developing antimicrobial systems from food matrices. His multidisciplinary patents have crossover value in pharmaceuticals, nutraceuticals, and environmental safety. These accolades represent the fusion of his engineering ingenuity with a vision for healthier communities.

🌍 LEGACY & FUTURE CONTRIBUTIONS TO GLOBAL HEALTH

Looking ahead, Professor Chouaïbi is poised to further integrate food engineering with global health initiatives. His future research aims to refine nanoencapsulation methods to deliver targeted nutritional therapies and anti-infective agents through everyday food products. His commitment to addressing malnutrition, microbial contamination, and diet-related diseases aligns with global health goals and sustainable development frameworks. By developing bioactive-rich ingredients from agricultural waste, he also promotes circular economy principles and food system sustainability. His work resonates deeply in low- and middle-income countries, where accessible, nutrition-based interventions are critical in combating infectious disease burdens. As a mentor and innovator, his legacy will extend through the scientists he inspires, the institutions he shapes, and the communities that benefit from his science. With over 50 peer-reviewed articles and involvement in cutting-edge international projects, Professor Chouaïbi's contribution to the intersection of food science and infectious disease control is both transformative and enduring. His vision positions food not just as nourishment, but as a strategic frontier in the fight against infectious diseases worldwide.

NOTABLE PUBLICATION

  • Title: Co-encapsulation of catechin and L-lysine in water-in-oil-in-water (W1/O/W2) double emulsion using membrane emulsification process: application in carrot based infant-purée
    Authors: Eya Soussi, Nayrouz Yahyaoui, Moncef Chouaibi, Salem Hamdi
    Journal: Journal of Food Measurement and Characterization
    Year: 2025

 

  • Title: Comparative study of Acacia tortilis subsp. raddiana gum of Tunisian origin and commercial Acacia senegal gum
    Authors: Khouloud Rigane, Moncef Chouaibi, Romdhane Karoui
    Journal: Journal of Food Measurement and Characterization
    Year: 2025

 

  • Title: Arbutus unedo fruit syrup as a fortifying agent: effect on physicochemical, microbiological, rheological, sensory and antioxidant properties of yoghurt
    Authors: I. Essaidi, M. Chouaibi, H. Haj Koubaier, S. Bouacida, A. Snoussi, Y. Abassi, N. Bouzouita
    Journal: Journal of Food Science and Technology
    Year: 2023

 

  • Title: Bioactive Phytochemicals from Pumpkin Seed Oil Processing By-products
    Authors: L. Rezig, K. Gharsallah, M. Chouaibi
    Journal: Reference Series in Phytochemistry (Book Chapter)
    Year: 2023

 

  • Title: Influence of Conservation Agriculture on Durum Wheat Grain, Dough Texture Profile and Pasta Quality in a Mediterranean Region
    Authors: I. Kerbouai, D. Sfayhi, K. Sassi, H.C. M’hamed, H. Jenfaoui, J. Riahi, S. Arfaoui, M. Chouaibi, Ben-... (author name appears truncated)
    Journal: Agriculture (Switzerland)
    Year: 2023

Bidyut Matubber – Antibiotic – Best Researcher Award

Published on by Infectious

Bidyut Matubber - Antibiotic - Best Researcher Award

Khulna Agricultural University - Bangladesh

AUTHOR PROFILE

GOOGLE SCHOLAR 

EARLY ACADEMIC PURSUITS 🎓

Dr. Bidyut Matubber’s academic foundation is deeply rooted in veterinary public health and food hygiene. He completed his Doctor of Veterinary Medicine (DVM) in 2017 from Patuakhali Science and Technology University, securing a commendable CGPA of 3.74. Demonstrating his passion for advanced learning, he pursued a Master of Veterinary Public Health and Food Hygiene with a major in Antimicrobial Resistance, graduating with a perfect CGPA of 4.00 in 2019. These formative years reflect a consistent commitment to academic excellence and laid the groundwork for his specialization in food microbiology. During his master's tenure, Dr. Matubber actively participated in hands-on research activities, including antibiogram studies and chromatographic analysis. His academic environment exposed him to a multidisciplinary research setting, fostering a deeper understanding of microbiological threats in food systems. This exposure played a pivotal role in shaping his career and interest in public health. With a solid base in microbiology, statistics, and biosafety, he was well-prepared to address complex public health concerns, particularly those linked to antimicrobial resistance. His early academic journey was not just a pursuit of degrees but a strategic investment toward a research-intensive future in veterinary science and food safety, setting the stage for his impactful contributions.

PROFESSIONAL ENDEAVORS 🧪

Dr. Bidyut Matubber’s professional career commenced with a focused approach toward academia and applied research. Since November 2020, he has been serving as an Assistant Professor in the Department of Microbiology and Public Health at Khulna Agricultural University. In this role, he spearheads research on antimicrobial resistance and chemical residues in food items such as meat and milk. His work extends to critical extension activities, strengthening collaboration between universities, research institutions, and livestock farmers. His contributions aim to bridge the gap between scientific discoveries and practical applications in food safety. Prior to this, Dr. Matubber held the position of Master Research Fellow at his alma mater, where he honed his research skills in statistical software such as SPSS and R. He has also undergone extensive training in laboratory biosafety, surveillance, foot-and-mouth disease investigation, and herd production management. These multidimensional experiences enrich his capacity as both a researcher and educator. Dr. Matubber is not confined to the laboratory; his outreach and on-ground surveys enable him to assess real-world challenges faced by food handlers and animal health workers. His professional endeavors reflect a dynamic balance between rigorous research and meaningful community engagement, ensuring relevance and impact in every project he undertakes.

RESEARCH CONTRIBUTIONS AND FOCUS 🔬

Dr. Bidyut Matubber’s research trajectory is anchored in the critical domains of antimicrobial resistance (AMR), food microbiology, and public health. His work scrutinizes the presence of antibiotic resistance and chemical residues in livestock products — particularly meat and milk — in southern Bangladesh. His findings have been published in several reputable national and international journals, reinforcing his reputation as a dedicated scientific voice in the food safety sector. Notably, his recent studies explore the microbial contamination of street foods and the prevalence of multidrug-resistant pathogens in urban meat markets. These investigations have significant implications for public health, especially in developing countries grappling with poor food hygiene infrastructure. Dr. Matubber is also a contributing author in interdisciplinary topics, ranging from student mental health during online learning to reproductive issues in livestock. His collaborative research style has earned him co-authorship with international scholars and local experts, highlighting the diverse scope of his academic inquiries. Moreover, his work on biofilm resistance in farm industries and the evaluation of organic acid alternatives to antibiotic growth promoters reflect his forward-thinking approach. Altogether, his research contributions aim not just to describe problems but to offer actionable, evidence-based solutions in public health microbiology.

AWARDS AND RECOGNITION 🏆

Dr. Bidyut Matubber’s exemplary contributions to veterinary public health and food microbiology have been widely acknowledged through prestigious accolades. He was awarded the NST Research Fellowship (2019) by the Ministry of Science and Technology, Bangladesh — a competitive grant that recognized his potential in the field of antimicrobial resistance. In 2020, he won the Best Poster Presentation Award at the 3rd Annual Scientific Conference organized by the Coastal Vet Society of Bangladesh, showcasing his ability to communicate research effectively to scientific audiences. Further acknowledging his innovation and commitment, the Ministry of Science and Technology honored him with the Technology Invention, Research, and Development Project (R&D) grants in both 2021 and 2022. Perhaps most significantly, he received the Best Researcher Award (2022) from the Khulna Agricultural University Teacher’s Association for his outstanding scholarly accomplishments. These accolades are not just ceremonial; they are powerful affirmations of Dr. Matubber’s enduring influence in microbiology and public health research. They reflect his relentless pursuit of scientific excellence, impactful community engagement, and forward-looking research that addresses urgent food safety challenges in Bangladesh. Each award underlines a milestone in his evolving career, cementing his place as a key thought leader in his domain.

IMPACT AND INFLUENCE 🌍

Dr. Matubber's research has far-reaching implications for public health policy and food safety in Bangladesh. His work on antimicrobial resistance in meat and milk serves as a wake-up call for food safety regulators and veterinary policymakers. By highlighting the presence of drug-resistant bacteria in widely consumed animal products, his studies provide a critical evidence base for shaping food inspection protocols and public awareness campaigns. Beyond his published findings, Dr. Matubber plays a pivotal role in academic and field-level training, educating young researchers and practitioners about biosafety, food hygiene, and AMR surveillance. His influence also extends into interdisciplinary domains, as seen in his co-authored work on student anxiety during e-learning and reproductive health in livestock. Dr. Matubber's ability to synthesize data into policy-relevant recommendations amplifies his impact beyond academia. As a faculty member, he actively mentors future scientists and contributes to the university's knowledge-sharing platforms. His integrated approach — combining lab research, fieldwork, teaching, and publication — creates a ripple effect of influence across public health, education, and rural livelihoods. Through conferences, training programs, and collaborative networks, Dr. Matubber continues to shape not only scientific discourse but also the operational realities of food safety and veterinary health in Bangladesh.

LEGACY AND FUTURE CONTRIBUTIONS 🔭

Dr. Bidyut Matubber’s academic journey and professional milestones lay the foundation for a legacy marked by scientific integrity, community relevance, and transformative impact. Looking ahead, he is poised to expand his research into broader themes like the environmental reservoirs of antimicrobial resistance, molecular epidemiology, and climate-linked zoonotic diseases. His ongoing projects involving the contamination levels in street food and multidrug-resistant pathogens in meats are likely to evolve into larger surveillance frameworks with regional or national scope. Moreover, Dr. Matubber envisions integrating genomic tools and AI-driven analytics into his research to better understand resistance mechanisms. As a faculty member, he aims to establish a specialized research hub within Khulna Agricultural University that focuses on foodborne pathogens and antibiotic resistance. His long-term goals include mentoring doctoral candidates and fostering international research collaborations, particularly in South Asia and Southeast Asia. With his background in both laboratory and field-based research, Dr. Matubber is ideally positioned to contribute to global initiatives like the WHO's One Health framework. His legacy will not only be defined by his publications or awards, but by the structural improvements he brings to food safety systems, academic training, and public health policies in Bangladesh and beyond.

SUMMARY OF ACHIEVEMENTS 🧾

Dr. Bidyut Matubber is a dynamic academic, microbiologist, and public health researcher based at Khulna Agricultural University. With over five years of expertise in food microbiology and antimicrobial resistance, his work has led to impactful research on contamination in meat, milk, and street foods across southern Bangladesh. He has co-authored numerous papers in reputed journals, participated in national training programs, and successfully acquired competitive grants. His professional tenure includes key roles as an Assistant Professor and Master Research Fellow, underscoring a consistent trajectory of growth. Recognized for both scientific innovation and practical relevance, he has received prestigious awards, including the NST Research Fellowship and the Best Researcher Award by his university. His research has informed public policy and raised awareness about food safety issues in underserved communities. By combining rigorous lab work, strategic field outreach, and teaching excellence, Dr. Matubber exemplifies a researcher whose work transcends academia to affect real-world change. His story is one of perseverance, interdisciplinary collaboration, and a passionate commitment to improving health outcomes through science.

NOTABLE PUBLICATION

  • Title: Anxiety and its determinants among undergraduate students during E-learning in Bangladesh amid COVID-19
    Authors: MN Hoque, A Hannan, S Imran, MA Alam, B Matubber, SM Saha
    Journal: Journal of Affective Disorders Reports, Volume 6, Article 100241, 2021

 

  • Title: Factors associated with food safety knowledge and practices among meat handlers in Bangladesh: a cross-sectional study
    Authors: MH Al Banna, TR Disu, S Kundu, BO Ahinkorah, K Brazendale, AA Seidu, ...
    Journal: Environmental Health and Preventive Medicine, Volume 26, Article 84, 2021

 

  • Title: Pernicious attitude of microbial biofilms in agri-farm industries: Acquisitions and challenges of existing antibiofilm approaches
    Authors: SH Toushik, A Roy, M Alam, UH Rahman, NK Nath, S Nahar, B Matubber, ...
    Journal: Microorganisms, Volume 10, Issue 12, Article 2348, 2022

 

  • Title: Evaluation of different parameters in relation to repeat breeding of cows at the coastal areas of Bangladesh
    Authors: B Matubber, AK Paul, S Das
    Journal: Research in Agriculture Livestock and Fisheries, Volume 5, Issue 1, Pages 49–55, 2018

 

  • Title: Antibiotic resistance and residue in chicken, cattle, buffalo and goat meats in different southern districts of Bangladesh
    Authors: B Matubber, FI Rume, MEH Kayesh, MM Rahman, MR Amin, MA Asgar, ...
    Journal: Asian-Australasian Journal of Food Safety and Security, Volume 5, Issue 1, Pages 19–26, 2021

Qingshuang Wang – Diagnosis of Infectious Diseases – Best Researcher Award

Published on by Infectious

Qingshuang Wang - Diagnosis of Infectious Diseases - Best Researcher Award

Changchun University of Science and Technology - China

AUTHOR PROFILE 

SCOPUS

ROOTS AND ACADEMIC FOUNDATION 🌱

Wang Qingshuang hails from Shuangyashan City in Heilongjiang Province. His academic journey began at Harbin Normal University, where he graduated from the Department of Biology in 2002. Driven by a deep curiosity in scientific advancement, he pursued a Ph.D. in Optics from the Changchun University of Science and Technology, completing it in 2015. His educational path blends biological sciences and optical research—an intersection that would later define his unique research pursuits. In 2005, he broadened his academic experience at Peking University School of Medicine, further shaping his research trajectory. Later, as a visiting scholar at the University of British Columbia in 2017, he gained international exposure, which enriched his scientific outlook. These early academic experiences cultivated a strong foundation for his multidisciplinary research career, particularly in molecular biology, nanotechnology, and biomedical optics.

SCIENTIFIC CAREER AND LEADERSHIP 🧪

Currently, Professor Wang Qingshuang serves as Vice Dean, Professor, and Doctoral Supervisor at the School of Life Sciences and Technology, Changchun University of Science and Technology. His academic roles are bolstered by his active participation in national scientific committees and provincial technology initiatives. As a dissertation and project reviewer, he contributes significantly to educational and scientific standards. His leadership extends into professional organizations such as the Jilin Society of Biochemistry and Molecular Biology and the Innovation and Translational Medicine Professional Committee. Professor Wang not only teaches but also mentors young researchers and supervises Ph.D. students, helping cultivate the next generation of scientific minds. His role as an executive and committee member in several scientific societies underlines his influence in shaping policy and research priorities in biochemistry, molecular diagnostics, and applied biotechnology across Jilin Province and beyond.

INNOVATION IN RESEARCH AND BIOMEDICAL TECHNOLOGY 🔬

With over a decade of research in nano-sustained-release and anti-tumor drugs, Professor Wang Qingshuang has made significant strides in biomedical innovation. His work integrates optical science with molecular biology to create effective delivery systems for therapeutic agents. As a principal investigator, he led a basic scientific research project under the State Administration of Science, Technology and Industry for National Defense and contributed to two National Natural Science Foundation projects. His portfolio includes more than ten key R&D projects in Jilin Province, underscoring his leading role in regional biotech innovation. With over 20 SCI-indexed publications and many more in EI and core journals, Professor Wang’s scientific output reflects both depth and practical impact. His unique approach bridges fundamental science with real-world medical applications, exemplifying the translational potential of interdisciplinary research in drug development and diagnostic systems.

COMBATING COVID-19 WITH SCIENCE 🦠

In 2020, amidst the COVID-19 pandemic, Professor Wang Qingshuang emerged as a key scientific contributor in China’s fight against the virus. Leading his team as the technical head, he developed and implemented droplet digital PCR technology for nucleic acid detection of the novel coronavirus. This advanced diagnostic tool significantly improved detection accuracy and efficiency. In a show of solidarity, Professor Wang's team donated these kits to frontline institutions such as West China Hospital of Sichuan University and People's Hospital of Wuhan University. His leadership and quick response not only aided immediate clinical efforts but also reinforced the value of rapid scientific mobilization during global health crises. For these efforts, his research group—the “Jilin Province Cross-Regional Gene Diagnosis Frontier Technology Science and Technology Innovation and Entrepreneurship Team”—received national recognition from the Ministry of Science and Technology for outstanding contributions in epidemic response.

HONORS AND SCHOLARLY RECOGNITION 🏅

Professor Wang Qingshuang’s research excellence has been celebrated with numerous accolades. He is a two-time recipient of the Jilin Province Science and Technology Award, a prestigious honor recognizing innovation and impact in scientific research. His mentorship in undergraduate innovation has also earned him several first and second prizes in the National Undergraduate Life Science Innovation and Entrepreneurship Competition, highlighting his dedication to education and student development. These awards not only affirm his scientific achievements but also showcase his commitment to fostering young talent in the life sciences. Moreover, his esteemed roles as a reviewer for national academic dissertations and technological projects reflect the scholarly community’s trust in his expertise. These cumulative recognitions illustrate a career defined by both intellectual rigor and influential guidance across the fields of life sciences, diagnostics, and medical biotechnology.

SCIENTIFIC IMPACT AND PUBLIC SERVICE 🌍

Beyond academic circles, Professor Wang Qingshuang’s work has had a measurable impact on public health and scientific policy. His COVID-19 diagnostic innovations directly contributed to safer and more accurate detection methods during a time of urgent global need. As a public contributor, he aligns scientific advancement with societal benefit, often integrating his research with regional health initiatives and policy-making through his role in the Jilin Health Management Society. His position at the interface of research, clinical application, and public welfare allows him to influence how science serves humanity. His vision combines high-level scientific rigor with real-world applications, improving not only patient outcomes but also strengthening regional research infrastructure. Through these actions, Professor Wang embodies the role of a scientist as both a discoverer and a servant of the public good.

LEGACY AND FUTURE ASPIRATIONS 🚀

Looking forward, Professor Wang Qingshuang aims to expand the frontiers of biomedical diagnostics and nano-drug delivery systems. His legacy is being etched not only in academic literature but also in the generation of scientists he mentors and the technological platforms he pioneers. As he continues to collaborate with national and international institutions, his research is expected to reach broader clinical applications and influence global healthcare innovation. He envisions building interdisciplinary laboratories that integrate optics, nanotechnology, and molecular medicine, paving the way for precision diagnostics and therapies. His commitment to translational science ensures that future endeavors will continue to bridge the gap between research labs and hospital wards. With an unrelenting passion for inquiry and innovation, Professor Wang is poised to leave a lasting mark on biomedical science and public health advancement.

NOTABLE PUBLICATION

Title: Fe₂VO₄@N−C cathode for high performance aqueous zinc and ammonium-ion batteries
Authors: Yinqiang Hu, Li Lin, Zhenyu Hu, Qingshuang Wang, Chunpeng Yang
Journal: Not specified (journal name not shown in the provided text)

Title: An electrochemical biosensor based on a novel nucleic acid isothermal amplification method for detecting pathogenic bacteria
Authors: Chuanna Xu, Shengjun Bu, Boyuan Jian, Qingshuang Wang, Jiayu Wan
Journal: Microchemical Journal, 2025

Title: High capacity and efficient dehydrogenation of aluminum hydride: Optimized by highly active TiN nanoparticles with low addition
Authors: Shaolei Zhao, Qingyun Shi, Long Liang, Limin Wang, Yong Cheng
Journal: Nano Research, 2025

Title: Thermosensitive Hydrogel Loaded with α-Mangostin for Enhanced Antitumor Effect of Doxorubicin
Authors: Tianhui Liu, Qingshuang Wang, Wenxin Geng, Zhe Zhang, Xiangru Feng
Journal: ACS Biomaterials Science and Engineering, 2025

Title: Nano-Based Strategies Aiming at Tumor Microenvironment for Improved Cancer Therapy
Authors: Tianhui Liu, Changshun Lu, Xue Jiang, Xiangru Feng, Qingshuang Wang
Journal: Not specified (journal name not shown in the provided text)